Smart Inhalers Market: Global Share, Size, Growth, Trends & Outlook ( 2022 – 2032 )
Smart inhalers also known as connected inhalers and sensors are advanced versions of the conventional respiratory inhalers. These are equipped with digital sensors which aid in tracking data such as dosage timing, monitoring the technique and use of the inhaler, and scheduling the next dosage. Smart Inhalers can generate alerts for everyday dosage using smart devices like phones or tablets connected to the sensors via the Bluetooth. They also gather data to enable professional care and have the potential to improve patients’ adherence to therapies and keep their condition under control.
Some of the drugs used in the inhalers include glucocorticoids, insulin, anti-cholinergic, and beta-agonists for the treatment and prevention of respiratory disorders including asthma and COPD.
The application of this digital technology has been successful in reducing the significant financial costs associated with suboptimal medication adherence, enhancing the respiratory diseases management, and improving the effectiveness of prescribed medications.
The global smart inhalers market is expected to grow at a CAGR of around 18.5% over the period of next 5 years.
The growth of this market is attributed towards major pertaining factors including; the growing prevalence of respiratory disorders & inflammatory diseases such as asthma & COPD globally and the burden on healthcare services as a result of this, the rising levels of air pollution worldwide, the proliferating adoption of smart inhalers across different regions, the growing awareness about the advantage of smart inhalers over conventional inhalers and the improving adherence rate driven by increasing preference and inclination towards the adoption of smart inhalers for the delivery of drugs directly to the respiratory tract of patients so as to increase the efficacy of drug delivery and maintain track record for monitoring daily medication etc.
Additionally, smart inhalers enable the gathering of vast amount of individual data which acts a significant resource for the identification of the potential hazards for the patients. This data proficiently aids in devising solutions for each of the hazards for their complete eradication. They also help community leaders identify core problems over a particular region which otherwise lead to further worsening in air quality and adverse effects on the pulmonary health of the local populace. This makes smart inhalers highly desired in the medical industry and helps in fueling of the market growth considerably.
Moreover, growing research and development activities coupled with increasing modernization leading to innovative technological advancements has been a continuous fashion in the healthcare sector. Rising adoption of digital technology and partnerships among prominent pharma manufacturers, software companies and others with increased focus on advancement in treatment methods, improved disease management and improved efficacy of prescribed medicines is comprehensively adding to the growth of the smart inhalers market.
Furthermore, other factors such as the benefits of smart inhalers ranging from reducing hospital admissions to improving the efficacy of medicines and reduction in the overall costs associated with the treatment of respiratory disorders, the surging focus towards advanced treatment protocols, the untapped market potential in developing regions with high population and dearth of healthcare amenities, the growing geriatric population and the increasing usage of smartphones, tablets & pad further propel the growth of the market.
However, factors such as the high price of smart inhalers and COPD & asthma treatments, data security concerns related to security devices, the lack of awareness regarding the symptoms of asthma and COPD and the technology across the globe, the limited availability of smart inhalers, the increasing practice of misinterpretation of information and the limited reimbursement scenario restrain the growth of this market.
SMART INHALERS MARKET SEGMENTATION:
- Dry Powder Inhaler
- Metered-Dose Inhaler
- Chronic Obstructive Pulmonary Disease (COPD)
By End User:
- Home-care Settings
- Hospitals & Clinics
- Respiratory Care Centers
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
The North American region held the largest share in the smart inhalers market in the past years and is expected to continue to remain at the top in the upcoming years also. The growth in this region can be attributed to factors such as the growing patient populace getting diagnosed with diseases like asthma and COPD in the region, the proliferating adoption of latest technologies in the region, growing digitalization in healthcare sector and rising collaboration between pharma and digital health companies in the region etc. Furthermore, the increasing per capita income, flexible regulatory scenario, favorable government policies and growing air pollution in the region also contribute to the region’s market growth. The U.S is the major contributor to the region.
The European region holds the second largest share in the smart inhalers market and is expected to witness substantial growth in the forthcoming years owing to factors which include the presence of well-established players of the region, the proliferating adoption of smart inhalers by hospitals and patients in the region, augmenting technological advancements in the field of healthcare in the region, the increasing prevalence of air pollution and surging initiatives for the purpose of spreading awareness regarding COPD, asthma and the use of technology for smart management of these conditions etc. The major contributor in the region is Germany.
The Asia Pacific region is the fastest growing regional market for smart inhalers. This region is anticipated to maintain its growth rate in the future years also. The growth can be accounted to factors such as the increasing incidences of respiratory diseases among the growing populace of the region, the rapid development of the healthcare infrastructure in the region, the increasing awareness regarding the use of digital devices for proper disease management in the region, the increasing presence of major players in the region and the increasing expenditure on the development of healthcare infrastructure in the region. Additionally, the surging disposable incomes of people and the rapid industrialization in the major economies of the region also effectively contribute to the region’s market growth. The major contributors in the region include India and China.
FEW KEY PLAYERS IN SMART INHALERS MARKET:
- Teva Pharmaceuticals
- H&T Presspart Manufacturing Ltd.
- Novartis AG
- Cohero Health
- Vectura Group
- Zeolr Technologies Pvt Ltd.
- Crux Product Design Ltd
- Amiko Digital Health Limited
- Gecko Health Innovations Inc.
- Findair Sp. z o. o
- Adherium Ltd.
- Inspiro Medical
- GlaxoSmithKline plc
- AstraZeneca plc
- Aptar Pharma
- Boehringer Ingelheim
- Propeller Health
- Other Players
- In January 2020, California-based startup, Cognita Labs won FDA clearance for its first device, a smart cap for inhalers used by people with asthma, chronic obstructive pulmonary disease and other respiratory disorders. The device, called CapMedic, sits on top of the inhaler and houses sensors that guide users and collect data for remote patient monitoring.
- In September 2020, Teva Respiratory, an affiliate of Teva Pharmaceutical Industries, completed its digital inhaler portfolio with the launch of two new products: the AirDuo Digihaler and the ArmonAir Digihaler. Both of the new inhalers are prescription inhalation powders designed to treat people with asthma 12 years and older. The Digihaler line is also said to be equipped with Bluetooth wireless technology that automatically records inhaler-use data every time the cap is opened or a user inhales.